@FiercePharma: Merck CEO's biggest accomplishment so far? Standing firm on R&D spending as $MRK got pounded, he tells AP: Report | Follow @FiercePharma
@EricPFierce: Happy anniversary, Bayer. A year after India granted first compulsory license for Nexavar, board rejects appeal. News | Follow @EricPFierce
> FDA reviewers highlighted a "plausible" risk of cancer with bone drugs containing calcitonin salmon and recommended their use be restricted to exclude osteoporosis patients. Report
> Arena Pharmaceuticals ($ARNA) said the Drug Enforcement Administration hasn't yet finalized the controlled substances designation on its yet-to-be-launched obesity drug Belviq. Report
> Elan ($ELN) will let stockholders share in the royalties from its multiple sclerosis drug Tysabri in an attempt to fend off a $6.5 billion buyout bid from RP Management. Report
> Private equity firm Warburg Pincus tapped a group of investment bankers to lead a Bausch + Lomb IPO that would raise as much as $1.5 billion. Report
> In the wake of safety scandals, Chinese officials have proposed a new, stronger agency to oversee the food and drug industries. Report
> Boehringer Ingelheim has teamed up with the online community PatientsLikeMe to help patients with idiopathic pulmonary fibrosis to monitor their health and connect with other patients. Report
@FierceMedDev: Special Report: Devicemakers plot paths out of CRM funk. Feature | Follow @FierceMedDev
@MarkHFierce: Toshiba's medical equipment division is expanding in South Korea. Release | Follow @MarkHFierce
@DamianFierce: Parexel says it's got its M&A eye on the Middle East and some small tech companies this year. Report | Follow @DamianFierce
> Stryker closes $764M deal for Chinese ortho giant. Article
> Toshiba Medical rolls out South Korean subsidiary. Story
Biotech News
@FierceBiotech: Popular this weekend: Celgene's blockbuster dreams fade as apremilast PhIII fails to excite. Story | Follow @FierceBiotech
@JohnCFierce: Doctors declare "functional cure" of an infant infected with HIV--A first for an infant. More | Follow @JohnCFierce
@RyanMFierce: J&J backs startup effort tackling Big Data-driven disease models. More from FierceBiotechIT.com | Follow @RyanMFierce
> Merck KGaA fashions its 6th biotech from Serono R&D wreckage. News
> Elan woos investors with a special dividend plan for Tysabri. Item
> Novartis CEO Jimenez focuses R&D on the new blockbuster paradigm. Report
> Celgene's blockbuster dreams fade as apremalist PhIII fails to excite. Story
CRO News
> Trial sites say Biogen, Forest, Bayer are top sponsors. Item
> Covance allies with M2Gen for personalized medicine, cancer trials. News
> Particle Sciences teams with Chinese CRO on solubility. More
> Capsugel bets on drug delivery with Encap buy. Report
> Synteract goes global with Harrison buyout. Article
Biotech IT News
> Could playing mobile phone games help advance cancer cures? More
> GSK jumps new IT hurdles in 'real-world' test of blockbuster hopeful. Editor's Corner
> Accelrys marks Q4 growth as buyouts weigh on bottom line. Report
> Biocon chief prescribes new tech, analytics to treat R&D woes in pharma. Story
> What Facebook and Google billionaires could do for overlooked biotech brains. Item
And Finally... Doctors say they've cured an infant born with HIV by giving her a cocktail of available drugs shortly after birth. Report